Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) General Information

Description

The gastrointestinal drugs commercialization rights.

Contact Information

Website
www.rebyota.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)‘s full profile, request access.

Request a free trial

Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)‘s full profile, request access.

Request a free trial

Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) FAQs

  • Where is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) headquartered?

    Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is headquartered in Switzerland.

  • What industry is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) in?

    Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)’s primary industry is Buildings and Property.

  • Is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) a private or public company?

    Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is a Private company.

  • What is the current valuation of Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)?

    The current valuation of Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is .

  • What is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)’s current revenue?

    The current revenue for Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is .

  • Who are Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)’s investors?

    Ferring has invested in Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights).

  • When was Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) acquired?

    Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) was acquired on 01-Sep-2026.

  • Who acquired Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)?

    Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) was acquired by RedHill Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process